| Product Code: ETC6186014 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Australias diagnostic market for NTDs is limited to specialized laboratories and research institutions, often serving diagnostic needs of travelers and immigrants. However, the demand for rapid and accurate diagnostic tools is supported by Australia`s participation in international disease surveillance and healthcare assistance programs in Asia-Pacific regions.
Diagnostics for NTDs in Australia are primarily relevant in travel clinics and academic research settings. Innovations in point-of-care testing and molecular diagnostics are shaping the market, particularly for diseases like dengue, leishmaniasis, and Chagas disease. Public health agencies support early detection through traveler screening protocols.
Challenges include limited access to rapid diagnostic tools, lack of standard diagnostic protocols, and minimal demand within the country, leading to poor commercial viability for diagnostics providers targeting the Australian healthcare market.
With a strong medical diagnostics infrastructure, Australia is well-positioned to lead in the diagnostics of NTDs, especially with portable and rapid diagnostic kits. Investors can fund start-ups focusing on early detection technologies and collaborate with NGOs or government-funded programs to extend diagnostic reach to underserved communities in neighboring countries.
Policies enabling collaboration between research institutions, universities, and biotech firms have led to advancements in diagnostic tools for NTDs. Government-funded initiatives, such as the Global Health program under the National Health and Medical Research Council (NHMRC), help Australian firms contribute to global diagnostic efforts while receiving domestic R&D support.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Neglected Tropical Diseases Diagnosis Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Neglected Tropical Diseases Diagnosis Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Neglected Tropical Diseases Diagnosis Market - Industry Life Cycle |
3.4 Australia Neglected Tropical Diseases Diagnosis Market - Porter's Five Forces |
3.5 Australia Neglected Tropical Diseases Diagnosis Market Revenues & Volume Share, By Disease, 2021 & 2031F |
3.6 Australia Neglected Tropical Diseases Diagnosis Market Revenues & Volume Share, By Method, 2021 & 2031F |
3.7 Australia Neglected Tropical Diseases Diagnosis Market Revenues & Volume Share, By Service Type, 2021 & 2031F |
3.8 Australia Neglected Tropical Diseases Diagnosis Market Revenues & Volume Share, By End use, 2021 & 2031F |
4 Australia Neglected Tropical Diseases Diagnosis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about neglected tropical diseases in Australia |
4.2.2 Government initiatives and funding for healthcare infrastructure and research |
4.2.3 Growing focus on preventive healthcare measures |
4.3 Market Restraints |
4.3.1 Limited access to healthcare services in remote areas |
4.3.2 Lack of skilled healthcare professionals specialized in neglected tropical diseases |
4.3.3 High costs associated with diagnostic tests and treatments |
5 Australia Neglected Tropical Diseases Diagnosis Market Trends |
6 Australia Neglected Tropical Diseases Diagnosis Market, By Types |
6.1 Australia Neglected Tropical Diseases Diagnosis Market, By Disease |
6.1.1 Overview and Analysis |
6.1.2 Australia Neglected Tropical Diseases Diagnosis Market Revenues & Volume, By Disease, 2021- 2031F |
6.1.3 Australia Neglected Tropical Diseases Diagnosis Market Revenues & Volume, By Dengue, 2021- 2031F |
6.1.4 Australia Neglected Tropical Diseases Diagnosis Market Revenues & Volume, By Chikungunya, 2021- 2031F |
6.1.5 Australia Neglected Tropical Diseases Diagnosis Market Revenues & Volume, By Rabies, 2021- 2031F |
6.1.6 Australia Neglected Tropical Diseases Diagnosis Market Revenues & Volume, By Leprosy, 2021- 2031F |
6.1.7 Australia Neglected Tropical Diseases Diagnosis Market Revenues & Volume, By Buruli ulcer, 2021- 2031F |
6.1.8 Australia Neglected Tropical Diseases Diagnosis Market Revenues & Volume, By Yaws, 2021- 2031F |
6.1.9 Australia Neglected Tropical Diseases Diagnosis Market Revenues & Volume, By Taeniasis/Cysticercosis, 2021- 2031F |
6.1.10 Australia Neglected Tropical Diseases Diagnosis Market Revenues & Volume, By Taeniasis/Cysticercosis, 2021- 2031F |
6.2 Australia Neglected Tropical Diseases Diagnosis Market, By Method |
6.2.1 Overview and Analysis |
6.2.2 Australia Neglected Tropical Diseases Diagnosis Market Revenues & Volume, By Conventional Method, 2021- 2031F |
6.2.3 Australia Neglected Tropical Diseases Diagnosis Market Revenues & Volume, By Molecular/Modern Method, 2021- 2031F |
6.3 Australia Neglected Tropical Diseases Diagnosis Market, By Service Type |
6.3.1 Overview and Analysis |
6.3.2 Australia Neglected Tropical Diseases Diagnosis Market Revenues & Volume, By Centralized Service, 2021- 2031F |
6.3.3 Australia Neglected Tropical Diseases Diagnosis Market Revenues & Volume, By POC Service, 2021- 2031F |
6.4 Australia Neglected Tropical Diseases Diagnosis Market, By End use |
6.4.1 Overview and Analysis |
6.4.2 Australia Neglected Tropical Diseases Diagnosis Market Revenues & Volume, By Clinical Labs, 2021- 2031F |
6.4.3 Australia Neglected Tropical Diseases Diagnosis Market Revenues & Volume, By Hospitals /Clinics, 2021- 2031F |
6.4.4 Australia Neglected Tropical Diseases Diagnosis Market Revenues & Volume, By Home Healthcare, 2021- 2031F |
7 Australia Neglected Tropical Diseases Diagnosis Market Import-Export Trade Statistics |
7.1 Australia Neglected Tropical Diseases Diagnosis Market Export to Major Countries |
7.2 Australia Neglected Tropical Diseases Diagnosis Market Imports from Major Countries |
8 Australia Neglected Tropical Diseases Diagnosis Market Key Performance Indicators |
8.1 Number of diagnosed cases of neglected tropical diseases in Australia |
8.2 Percentage increase in funding for neglected tropical diseases diagnosis and research |
8.3 Adoption rate of new diagnostic technologies for neglected tropical diseases in Australia |
8.4 Number of healthcare facilities offering services for neglected tropical diseases |
8.5 Patient satisfaction scores related to the quality of diagnosis and treatment for neglected tropical diseases |
9 Australia Neglected Tropical Diseases Diagnosis Market - Opportunity Assessment |
9.1 Australia Neglected Tropical Diseases Diagnosis Market Opportunity Assessment, By Disease, 2021 & 2031F |
9.2 Australia Neglected Tropical Diseases Diagnosis Market Opportunity Assessment, By Method, 2021 & 2031F |
9.3 Australia Neglected Tropical Diseases Diagnosis Market Opportunity Assessment, By Service Type, 2021 & 2031F |
9.4 Australia Neglected Tropical Diseases Diagnosis Market Opportunity Assessment, By End use, 2021 & 2031F |
10 Australia Neglected Tropical Diseases Diagnosis Market - Competitive Landscape |
10.1 Australia Neglected Tropical Diseases Diagnosis Market Revenue Share, By Companies, 2024 |
10.2 Australia Neglected Tropical Diseases Diagnosis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |